Maccura to hold extraordinary general meeting, manages funds

Maccura Biotechnology Co., Ltd. announced it would hold its third extraordinary general meeting of shareholders in 2025 on October 15, 2025, at 2 p.m. The meeting, to be conducted via both on-site and online voting, will address several critical proposals, including adjustments to the organizational structure, revisions to the articles of association, and updates to various corporate governance policies. Shareholders will also vote on providing guarantees for dealer bank credit lines. Proposal 1.00 requires a special resolution, and Proposal 2.00 will be voted on item by item, with special provisions for small and medium investors.

The company also reported on its treasury management activities, noting the maturity and redemption of a 5,000,000 yuan wealth management product with China Everbright Bank. This product yielded an actual income of 22,530,000 yuan, consistent with expectations. Maccura subsequently utilized 5,000,000 yuan of its idle raised funds to purchase a new wealth management product from China Everbright Bank, a principal-protected floating-rate income product with a maturity date of October 13, 2026, and an expected annualized yield of 0.55%-1.75%.

The decision to continue using idle raised funds for wealth management was approved by the company's sixth board of directors and supervisors, aiming to enhance capital efficiency while ensuring project development.